Physician profile
Jay A Cline
NPI 1922319813
$1,906.47
in general payments reported to CMS, 2019-2025
12 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $71.87 · 2021: $151 · 2022: $179 · 2023: $194 · 2024: $718 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $439.34 | 2023-2025 | Dupixent |
| Glaxosmithkline, LLC. | $357.90 | 2022-2025 | Nucala |
| Inspire Medical Systems, INC. | $306.88 | 2024-2025 | Inspire |
| Stryker Corporation | $256.84 | 2019-2021 | |
| Genzyme Corporation | $158.93 | 2019-2024 | |
| Depuy Synthes Sales INC. | $124.88 | 2024 | Matrixmidface, Rapidsorb, Matrixmandible |
| Optinose US, INC. | $118.67 | 2020-2025 | |
| Aerin Medical INC. | $63.84 | 2024-2025 | |
| Cochlear Americas | $34.51 | 2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Novartis Pharmaceuticals Corporation | $15.79 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.40 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.